Navigation Links
Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy
Date:11/5/2007

mcg and 1800 mcg. The most common adverse events were fatigue, headache, arthralgia (joint pain), myalgia (muscle pain), insomnia, nausea, cough, and pyrexia (fever). Discontinuation rates due to adverse events were: 4.2% for the 1200 mcg every four weeks group; 17.4% for the 900 mcg every two weeks group; 4.2% for the 1200 mcg every two weeks group; 9.1% for the 1500 mcg every two weeks group; and 18.2% for the 1800 mcg every two weeks group. Hematologic reductions stabilized by Week 8, were well managed with dose reductions, and returned to baseline following the completion of therapy.

"The results emerging from our Phase 2 program continue to support our belief that Albuferon could become an important therapeutic option for patients with chronic hepatitis C, including those that have failed prior therapy," said Mani Subramanian, M.D., Ph.D., Senior Director of Clinical Research, Infectious Diseases, HGS.

About Albuferon

Albuferon is a novel long-acting form of interferon alpha created by HGS using its proprietary albumin fusion technology. Albuferon results from the genetic fusion of human albumin and interferon alpha. Human albumin is the most prevalent naturally occurring blood protein in the human circulatory system, persisting in circulation in the body for more than 20 days. Research shows that genetic fusion of therapeutic proteins to human albumin decreases clearance and prolongs the half-life of the proteins. Recombinant interferon alpha is approved for the treatment of hepatitis C, hepatitis B and a number of cancers.

Albuferon is being developed by HGS and Novartis for the treatment of chronic hepatitis C under a worldwide co-development and commercialization agreement entered into in June 2006. HGS and Novartis will co-commercialize Albuferon in the United States and will share clinical development costs, U.S. commercialization costs and U.S. profits equally. Novartis will be responsible for commercialization in the rest of the
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... PITTSBURGH , June 3, 2015 ... company, today announced that the Company will present at Goldman ... June 9, 2015. The presentation is scheduled to begin at ... Interested parties can access a live webcast of the presentation ... http://mylan.com/investors .   Mylan is a global pharmaceutical ...
(Date:6/3/2015)... June 3, 2015   Health Data Consortium (HDC) , a public-private ... collaborations using data to improve health and healthcare, today ... Director of the Office of Enterprise Data and Analytics ... as the recipient of this year,s Health Data ... data in innovative ways to help improve the quality ...
(Date:6/3/2015)... June 3, 2015 Creekridge Capital, an independent, ... sales channels by adding two new sales representatives. ... Regional Sales Manager and Stefanie Stark joined ... Puma comes to Creekridge with over 20 years of ... at Creekridge, Mr. Puma will be responsible for identifying, ...
Breaking Medicine Technology:CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 2CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 4Creekridge Capital Strengthens Sales Team 2
... CHICAGO, Oct. 21 GelScrubs, the healthcare industry,s ... announces its inclusion in the prestigious Inc. 5000 ... the list serves as a highly regarded who,s ... America. (Logo:   http://photos.prnewswire.com/prnh/20100817/INC5000LOGO ) ...
... Hospira, Inc. (NYSE: HSP ), the ... launch of piperacillin and tazobactam for injection in the ... Zosyn®, the world,s leading injectable antibiotic, from Pfizer (Wyeth). ... more than $855 million. Piperacillin and ...
Cached Medicine Technology:GelScrubs Named to 2010 Inc. 5000 Ranking 2Hospira Launches Piperacillin and Tazobactam for Injection in the United States 2Hospira Launches Piperacillin and Tazobactam for Injection in the United States 3
(Date:6/3/2015)... 03, 2015 blingsting announces their new ... car's glove compartment or can be strapped onto a ... features a pointed tip that will allow the user ... blade that can cut through a seatbelt or carseat ... Glammer include:, ,         Easily break a window ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 EMBARGOED FOR RELEASE ... Birth Weight Associated with Proximity of Mother’s Home to Gas ... close to a high density of natural gas wells drilled ... lower birth weights than women living farther from such wells, ... Public Health analysis of southwestern Pennsylvania birth records. ...
(Date:6/3/2015)... The Canton Group, a leading web ... announced today that Tim Dodge has joined the company ... The Canton Group as it implements an ambitious ... , Tim is a tech industry veteran who has ... technology companies. Before joining The Canton Group, Tim was ...
(Date:6/3/2015)... June 03, 2015 On the heels of ... billion industry by 2020 ( click here to review ... scientists believe Baltimore has the talent to become ... which genetic code and other biological data are collected and ... “Baltimore contains all the elements of a perfect storm ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Alberto Grignolo, ... at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award ... level of excellence, and commitment to service on a ... Global Connector Award that annually recognizes one DIA member ... advanced the mission of DIA to foster innovation to ...
Breaking Medicine News(10 mins):Health News:blingsting Announces All New Car Safety Tool The Glammer 2Health News:Fracking Proximity Associated with Lower Birth Weight 2Health News:Fracking Proximity Associated with Lower Birth Weight 3Health News:Fracking Proximity Associated with Lower Birth Weight 4Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3
... variety of therapeutic categories can be screened to identify effective ... for publication in the Endocrine Society,s Journal of Clinical ... rapidly be implemented into a clinical trial to test how ... chemical agents capable of modulating a disease is a long ...
... trial found that rilonacept, an inhibitor of the ... that occur when initiating uric acid-lowering therapy. Results ... targeted therapy in prevention of gout flaresshow rilonacept ... infections or treatment-related serious adverse events reported. Full ...
... WEDNESDAY, Jan. 4 (HealthDay News) -- Nearly one in four ... that her risk of getting other sexually transmitted diseases is ... commonly transmitted sexually transmitted infection (STI) in the United States, ... to 19 infected. Some virus types can raise the ...
... women against infection from one of the two types of herpes ... New England Journal of Medicine . The vaccine was ... did not protect women from herpes simplex virus type 2 (HSV-2). ... herpes caused by HSV-1 58 percent fewer -- in women ...
... By Mary Brophy Marcus HealthDay Reporter , ... against the hepatitis C virus, which can cause severe liver ... it,s likely years away, researchers are reporting. , , There ... estimated 170 million people worldwide. , , Like HIV, the ...
... (HealthDay News) -- New research shows that women with ... from depression and so-called "disordered eating," regardless of whether ... that most [study] participants frequently adhered to a gluten-free ... to increased vitality, lower stress, decreased depressive symptoms and ...
Cached Medicine News:Health News:New drug screening identifies chemical agents with potent anti-cancer activity 2Health News:Clinical trial demonstrates that rilonacept significantly reduces gout flares 2Health News:Clinical trial demonstrates that rilonacept significantly reduces gout flares 3Health News:Many Teen Girls Mistakenly Think HPV Vaccines Cut Risk for All STDs 2Health News:Many Teen Girls Mistakenly Think HPV Vaccines Cut Risk for All STDs 3Health News:Research shows progress toward a genital herpes vaccine 2Health News:Research shows progress toward a genital herpes vaccine 3Health News:Novel Hepatitis C Vaccine Shows Some Early Promise 2Health News:Novel Hepatitis C Vaccine Shows Some Early Promise 3Health News:Celiac Disease in Women Linked to Depression Risk 2
... peripheral nerve stimulator automatically ... nerve locator or a ... upon which patient lead ... NSL-5 electrode lead set, ...
Low pressure automatic tourniquet with manual time. Includes extension hose and spiral replacement hose....
... Universal Hand Holder and Retractor Set ... hand in any position needed. Ball ... or tendon hooks, fixate the hand ... the patient's hand held firmly, the ...
Stryker Instruments, the leader in cordless power, advances orthopaedics with the power, speed, versatility, reliability and performance through its heavy duty powered instruments....
Medicine Products: